Qube Research & Technologies (QRT)
KLRS

Qube Research & Technologies (QRT)’s Kalaris Therapeutics KLRS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.1K Buy
+11,103
New +$98.5K ﹤0.01% 3140
2025
Q1 		– Sell
-632
Closed -$6.11K – 3968
2024
Q4 		$6.11K Sell
632
-861
-58% -$13K ﹤0.01% 3285
2024
Q3 		$27.8K Sell
1,493
-1,934
-56% -$33.8K ﹤0.01% 2941
2024
Q2 		$57K Sell
3,427
-1,254
-27% -$22.1K ﹤0.01% 2720
2024
Q1 		$81.3K Sell
4,681
-3,885
-45% -$63.4K ﹤0.01% 3378
2023
Q4 		$134K Buy
+8,566
New +$338K ﹤0.01% 2989
2021
Q1 		– Sell
-272
Closed -$240K – 2501
2020
Q4 		$240K Buy
+272
New +$209K ﹤0.01% 1459

Other funds holding KLRS

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s KLRS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Kalaris Therapeutics (KLRS) in Q1 2026: 11,103 shares worth $64.1K. The stake represents ﹤0.01% of the portfolio and ranks #3140 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in KLRS as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in KLRS in Q4 2020 and has held it in 7 quarters since. The position peaked at $240K in Q4 2020. 58 funds tracked by Wall St. Rank hold KLRS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 11,103 shares of Kalaris Therapeutics worth $64.1K as of Q1 2026.
  • Kalaris Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Kalaris Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3140 holding.
  • Qube Research & Technologies (QRT) first reported a position in Kalaris Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Kalaris Therapeutics position peaked at $240K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.